163 related articles for article (PubMed ID: 18332089)
1. Small glutamine-rich tetratricopeptide repeat-containing protein alpha (SGTA), a candidate gene for polycystic ovary syndrome.
Goodarzi MO; Xu N; Cui J; Guo X; Chen YI; Azziz R
Hum Reprod; 2008 May; 23(5):1214-9. PubMed ID: 18332089
[TBL] [Abstract][Full Text] [Related]
2. Small glutamine-rich tetratricopeptide repeat-containing protein alpha is present in human ovaries but may not be differentially expressed in relation to polycystic ovary syndrome.
Butler MS; Yang X; Ricciardelli C; Liang X; Norman RJ; Tilley WD; Hickey TE
Fertil Steril; 2013 Jun; 99(7):2076-83.e1. PubMed ID: 23433514
[TBL] [Abstract][Full Text] [Related]
3. FEM1A and FEM1B: novel candidate genes for polycystic ovary syndrome.
Goodarzi MO; Maher JF; Cui J; Guo X; Taylor KD; Azziz R
Hum Reprod; 2008 Dec; 23(12):2842-9. PubMed ID: 18757445
[TBL] [Abstract][Full Text] [Related]
4. Harnessing expression data to identify novel candidate genes in polycystic ovary syndrome.
Jones MR; Chua A; Chen YD; Li X; Krauss RM; Rotter JI; Legro RS; Azziz R; Goodarzi MO
PLoS One; 2011; 6(5):e20120. PubMed ID: 21611153
[TBL] [Abstract][Full Text] [Related]
5. Family-based analysis of candidate genes for polycystic ovary syndrome.
Ewens KG; Stewart DR; Ankener W; Urbanek M; McAllister JM; Chen C; Baig KM; Parker SC; Margulies EH; Legro RS; Dunaif A; Strauss JF; Spielman RS
J Clin Endocrinol Metab; 2010 May; 95(5):2306-15. PubMed ID: 20200332
[TBL] [Abstract][Full Text] [Related]
6. Polymorphisms and haplotypes of insulin-like factor 3 gene are associated with risk of polycystic ovary syndrome in Indian women.
Shaikh N; Dadachanji R; Meherji P; Shah N; Mukherjee S
Gene; 2016 Feb; 577(2):180-6. PubMed ID: 26625974
[TBL] [Abstract][Full Text] [Related]
7. First evidence of genetic association between AKT2 and polycystic ovary syndrome.
Goodarzi MO; Jones MR; Chen YD; Azziz R
Diabetes Care; 2008 Dec; 31(12):2284-7. PubMed ID: 18768676
[TBL] [Abstract][Full Text] [Related]
8. Association study of androgen signaling pathway genes in polycystic ovary syndrome.
Ketefian A; Jones MR; Krauss RM; Chen YD; Legro RS; Azziz R; Goodarzi MO
Fertil Steril; 2016 Feb; 105(2):467-73.e4. PubMed ID: 26493122
[TBL] [Abstract][Full Text] [Related]
9. SGTA: a new player in the molecular co-chaperone game.
Philp LK; Butler MS; Hickey TE; Butler LM; Tilley WD; Day TK
Horm Cancer; 2013 Dec; 4(6):343-57. PubMed ID: 23818240
[TBL] [Abstract][Full Text] [Related]
10. DENND1A gene variants in Bahraini Arab women with polycystic ovary syndrome.
Gammoh E; Arekat MR; Saldhana FL; Madan S; Ebrahim BH; Almawi WY
Gene; 2015 Apr; 560(1):30-3. PubMed ID: 25626177
[TBL] [Abstract][Full Text] [Related]
11. A functional GNAQ promoter haplotype is associated with altered Gq expression and with insulin resistance and obesity in women with polycystic ovary syndrome.
Klenke S; Tan S; Hahn S; Mann K; Hauner H; Manthey I; Peters J; Siffert W; Frey UH
Pharmacogenet Genomics; 2010 Aug; 20(8):476-84. PubMed ID: 20562673
[TBL] [Abstract][Full Text] [Related]
12. [Genetic aspects of polycystic ovary syndrome].
Jakubowski L
Endokrynol Pol; 2005; 56(3):285-93. PubMed ID: 16350721
[TBL] [Abstract][Full Text] [Related]
13. Vitamin D receptor and binding protein polymorphisms in women with polycystic ovary syndrome: a case control study.
Song DK; Lee H; Hong YS; Sung YA
BMC Endocr Disord; 2019 Dec; 19(1):145. PubMed ID: 31870342
[TBL] [Abstract][Full Text] [Related]
14. Vascular endothelial growth factor (VEGFA) gene variation in polycystic ovary syndrome in a Tunisian women population.
Ben Salem A; Megdich F; Kacem O; Souayeh M; Hachani Ben Ali F; Hizem S; Janhai F; Ajina M; Abu-Elmagd M; Assidi M; Al Qahtani MH; Mahjoub T
BMC Genomics; 2016 Oct; 17(Suppl 9):748. PubMed ID: 27766947
[TBL] [Abstract][Full Text] [Related]
15. Association of vitamin D receptor gene polymorphisms with polycystic ovary syndrome among Indian women.
Dasgupta S; Dutta J; Annamaneni S; Kudugunti N; Battini MR
Indian J Med Res; 2015 Sep; 142(3):276-85. PubMed ID: 26458343
[TBL] [Abstract][Full Text] [Related]
16. Genetic variant in vitamin D-binding protein is associated with metabolic syndrome and lower 25-hydroxyvitamin D levels in polycystic ovary syndrome: A cross-sectional study.
Santos BR; Lecke SB; Spritzer PM
PLoS One; 2017; 12(3):e0173695. PubMed ID: 28278285
[TBL] [Abstract][Full Text] [Related]
17. Genetic variations in the 3'-untranslated region of SLC18A2 are associated with serum FSH concentration in polycystic ovary syndrome patients and regulate gene expression in vitro.
Li Q; Yan Z; Kuang Y; Zhou X; Jin L; He L; Sun X; Tao T; Wang L
Hum Reprod; 2016 Sep; 31(9):2150-7. PubMed ID: 27354380
[TBL] [Abstract][Full Text] [Related]
18. Lipin 1 gene polymorphisms in polycystic ovary syndrome.
Mlinar B; Ferk P; Pfeifer M; Geršak K; Marc J
Horm Metab Res; 2011 Jun; 43(6):427-32. PubMed ID: 21448847
[TBL] [Abstract][Full Text] [Related]
19. Molecular cloning of canine co-chaperone small glutamine-rich tetratricopeptide repeat-containing protein α (SGTA) and investigation of its ability to suppress androgen receptor signalling in androgen-independent prostate cancer.
Kato Y; Ochiai K; Michishita M; Azakami D; Nakahira R; Morimatsu M; Ishiguro-Oonuma T; Yoshikawa Y; Kobayashi M; Bonkobara M; Kobayashi M; Takahashi K; Watanabe M; Omi T
Vet J; 2015 Nov; 206(2):143-8. PubMed ID: 26346258
[TBL] [Abstract][Full Text] [Related]
20. Relation of resistin gene variants to resistin plasma levels and altered susceptibility to polycystic ovary syndrome: A case control study.
Al-Awadi AM; Saldhana FL; Bauyrzhanova Z; Nemr R; Mahmood NA; Almawi WY
Am J Reprod Immunol; 2023 Jul; 90(1):e13731. PubMed ID: 37382171
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
